Tanya Zarkhina
Family Medicine · Brooklyn, NYNPI 1710602552
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 34.0% of the total. Among family medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $57.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Boehringer Ingelheim$937
- Teva Pharmaceuticals USA, Inc.$343
- Lilly USA, LLC$294
- AstraZeneca$292
- Incyte Corporation$276
- plus $2K from 20 others
What the payments were for
- Food & beverage$5,865100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $1,991 |
| Boehringer Ingelheim | 15 | $937 |
| Teva Pharmaceuticals USA, Inc. | 3 | $343 |
| Lilly USA, LLC | 4 | $294 |
| AstraZeneca | 4 | $292 |
| Incyte Corporation | 3 | $276 |
| GSK | 3 | $266 |
| Scilex Pharmaceuticals Inc. | 5 | $238 |
| Kowa Pharmaceuticals America, Inc. | 5 | $225 |
| Ardelyx, Inc. | 6 | $184 |
| Verona Pharma, Inc. | 1 | $145 |
| E.r. Squibb & Sons, L.L.C. | 2 | $139 |
| Antares Pharma, Inc. | 1 | $102 |
| Novo Nordisk | 3 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $56 |
| Amgen | 2 | $43 |
| Merck | 2 | $37 |
| Exact Sciences | 1 | $33 |
| Nestle Healthcare Nutrition Inc. | 1 | $30 |
| Amarin Pharma, Inc. | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Phadia US Inc. | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Shield Therapeutics Inc | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Harmony Biosciences LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,865 in reported general payments places this provider in the 90th percentile of 4,321 family medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 27 | $26,389 |
| LinzessLinaclotide | 40 | $21,261 |
| JardianceEmpagliflozin | 36 | $21,095 |
| ZenpepLipase/Protease/Amylase | 16 | $21,057 |
| VascepaIcosapent Ethyl | 50 | $19,553 |
| EliquisApixaban | 26 | $19,197 |
| CreonLipase/Protease/Amylase | 12 | $15,623 |
| EntrestoSacubitril/Valsartan | 17 | $10,902 |
| Diclofenac Sodium | 30 | $9,361 |
| MyrbetriqMirabegron | 11 | $4,868 |
| Dexlansoprazole DrDexlansoprazole | 26 | $3,894 |
| SynthroidLevothyroxine Sodium | 47 | $2,172 |
| Metoprolol Succinate | 52 | $622 |
| Rosuvastatin Calcium | 102 | $606 |
| Olmesartan Medoxomil | 47 | $559 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon, Synthroid | $1,991 | $39,05699 claims |
| Lilly USA, LLCTrulicity | $294 | $26,38927 claims |
| Boehringer IngelheimJardiance | $937 | $21,09536 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $23 | $4617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,321 family medicine providers in New York.
Other family medicine in Brooklyn
- Walford LindoBrooklyn$104K
- Fu Fu HeBrooklyn$101K
- Jonathan ChangBrooklyn$66K
- Rui TengBrooklyn$39K
- Wei WangBrooklyn$26K
- Raymond ChanBrooklyn$25K
- Mikhail KorogluyevBrooklyn$24K
- Louis BonavitaEast Syracuse$674K
- Martin MahoneyBuffalo$520K
- Scott BrehautClinton$514K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.